Immunova

Funding and NIH signals

• NIH award NIH awarded $460K (SBIR Phase I 1R43AG102094-01, new, notice Sep 17, 2026). NIH RePORTER 1R43AG102094-01 (Sep 17, 2026)
  Evidence (1 event)

  • Sep 17, 2026 · NIH RePORTER 1R43AG102094-01
    Organization: IMMUNOVA, LLC; City/State: GAINESVILLE, FL; Project number: 1R43AG102094-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 459616; Administering IC: National Institute on Aging; Project title: Mitigating Age-Related Cognitive Decline through a First-in-Class Lipid Neurogenic Therapy; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals